Read, Watch or Listen

President Trump signed a memorandum targeting misleading pharmaceutical advertising on social media. The administration will send cease-and-desist letters and warnings to companies promoting drugs without disclosing risks, particularly those using influencers without clear paid-spokesperson disclosures. This action, while stopping short of a complete advertising ban, aims to enforce existing laws ensuring transparent drug information and level the playing field for pharmaceutical companies. The move follows concerns about low-quality information and lack of risk disclosure in social media drug ads.

Prepared by Lauren Mitchell and reviewed by editorial team.